Chapter 30 Acute Coronary Syndrome Q&A (1 of 20) Sample Questions

1. MJ is a 49 year old woman who was recently admitted to the hospital after stating that she is experiencing severe chest pain, sweating, nausea and vomiting. Upon presentation to hospital emergency ECG and serum cardiac biomarker including creatine kinase- MB and troponin I tests were performed. Hospitalemergency provided the diagnosis of ST elevated myocardial infarction with blockade in right artery. Within 90 minutes of arrival of hospital emergency performed percutaneous infusion (PCI) and metal stent is placed to within right artery to restore blood flow to infarction area. Patients with acute coronary syndrome who had STEMI are at high risk of recurrent event as well as development of secondary complication. Antiplatelets therapy is critical for preventing recurrent thrombosis and particular important for patient who has received stent. Which of the following dual antiplatelet therapy should be continued for minimum 12 months?
  1. A. Acetyl Salicylic Acid (ASA)
  2. B. ASA/Dypridamole
  3. C. ASA/Clopidogrel
  4. D. ASA/Prasugrel
Ans: D
Tips: The use of Prasugrel should be considered in those patients with ACS undergoing stent implantation that is at higher risk for stent thrombosis (previous stent thrombosis, STEMI, history of diabetes mellitus).